The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: A CTF study

被引:14
|
作者
Gadducci, A
Landoni, F
Maggino, T
Sartori, E
Zola, P
Fanucchi, A
机构
[1] UNIV MILAN,BRANCH 3,DEPT OBSTET & GYNECOL,MONZA,MILANO,ITALY
[2] UNIV PADUA,DEPT OBSTET & GYNECOL,PADUA,ITALY
[3] UNIV BRESCIA,DEPT OBSTET & GYNECOL,BRESCIA,ITALY
[4] UNIV TURIN,DEPT OBSTET & GYNECOL,TURIN,ITALY
关键词
D O I
10.1006/gyno.1996.0312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This retrospective study assessed 46 patients with advanced ovarian cancer who had elevated preoperative serum CA 125 (>35 U/ml) and who had another serum CA 125 assay 6-9 days after surgery, Preoperative CA 125 levels were similar in patients with residual disease below 20 mm and in those with larger residuum, The postoperative decline of serum CA 125 was significantly higher in patients with small residual disease at any preoperative serum CA 125 value, By taking 60% as the cutoff of CA 125 decline, the diagnostic accuracy of this parameter in discriminating between patients with residual disease below or above 20 mm improved progressively when we considered patients with increasing preoperative antigen values, However, even in the subset of patients with preoperative serum CA 125 above 400 U/ml, 2 of the 20 patients with less than 20 mm residual disease had a percentage reduction of antigen levels lower than 60%, whereas 5 of the 10 patients with larger than 20 mm residuum had a CA 125 decline higher than 60%. Therefore, we believe that the perioperative changes of CA 125 levels have a limited clinical relevance in the mangagement of patients with ovarian cancer. (C) 1996 Academic Press, Inc.
引用
收藏
页码:234 / 237
页数:4
相关论文
共 50 条
  • [1] THE DECLINE OF CA 125 LEVEL AFTER SURGERY REFLECTS THE SIZE OF RESIDUAL OVARIAN-CANCER
    BRAND, E
    LIDOR, Y
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (01): : 29 - 32
  • [2] Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Zhang, Dan
    Jiang, Yu-xia
    Luo, Shu-juan
    Zhou, Rong
    Jiang, Qing-xiu
    Linghu, Hua
    CLINICA CHIMICA ACTA, 2018, 484 : 32 - 35
  • [3] Correlation between CA 125 and interleukin 10 serum levels in patients with ovarian cancer
    Petrov, J.
    CLINICA CHIMICA ACTA, 2019, 493 : S119 - S119
  • [4] Decline of serum CA125 levels in the immediate postoperative period after primary cytoreductive surgery in patients with stage IIIC ovarian carcinoma: Independent predictor of prognosis
    Zivanovic, O.
    Eisenhauer, E. L.
    Sonoda, Y.
    Levine, D. A.
    Abu-Rustum, N. R.
    Brown, C. L.
    Barakat, R. R.
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S35 - S35
  • [5] Relationship between Ca-125 serum levels and FDG PET-CT in recurrent ovarian cancer
    Palomar Munoz, A.
    Cordero Garcia, J.
    Gomez Lopez, O.
    Garcia Vicente, A.
    Gimenez Londono, G.
    Soriano Castrejon, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S473 - S473
  • [6] The role of extended chemotherapy in patients with advanced ovarian cancer with high posttreatment serum CA125 levels
    Kang, S.
    Kim, T.
    Seo, S.
    Kim, B.
    Bae, D.
    Park, S.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S102 - S102
  • [7] Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels
    Kang, Sokbom
    Kim, Tae-Joong
    Seo, Sang-Soo
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Park, Sang-Yoon
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 72 (01) : 50 - 54
  • [8] CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer
    Memarzadeh, S
    Lee, SB
    Berek, JS
    Farias-Eisner, R
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 120 - 124
  • [9] Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
    Nakamura, Kazuto
    Kitahara, Yoshikazu
    Nishimura, Toshio
    Yamashita, Soichi
    Kigure, Keiko
    Ito, Ikuro
    Kanuma, Tatsuya
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [10] Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
    Kazuto Nakamura
    Yoshikazu Kitahara
    Toshio Nishimura
    Soichi Yamashita
    Keiko Kigure
    Ikuro Ito
    Tatsuya Kanuma
    World Journal of Surgical Oncology, 18